Dongwei Su Selected Research

Immunotherapy

4/2022

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dongwei Su Research Topics

Disease

4	Breast Neoplasms (Breast Cancer) 04/2022 - 01/2010
2	Neoplasms (Cancer) 04/2022 - 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Papillary Thyroid Cancer 01/2017
1	Nodular Goiter 09/2011
1	Goiter 09/2011

Drug/Important Bio-Agent (IBA)

2	Long Noncoding RNAIBA 04/2022 - 01/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2017 - 09/2011
1	EphA1 Receptor (Eph Receptor)IBA 01/2021
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 01/2017
1	EnzymesIBA 01/2017
1	Oxygen (Dioxygen)IBA 01/2017
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 09/2011
1	Capecitabine (Xeloda)FDA Link 01/2010

Therapy/Procedure

1	Immunotherapy 04/2022